Found: 33
Select item for more details and to access through your institution.
Hydroxyurea and hydroxamic acid derivatives as antitumor drugs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 213, doi. 10.1007/s00280-009-0991-z
- By:
- Publication type:
- Article
Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 223, doi. 10.1007/s00280-008-0833-4
- By:
- Publication type:
- Article
Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 233, doi. 10.1007/s00280-008-0853-0
- By:
- Publication type:
- Article
Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 243, doi. 10.1007/s00280-008-0854-z
- By:
- Publication type:
- Article
Enhancement of the in vivo antitumor activity of clofarabine by 1-β- d-[4-thio-arabinofuranosyl]-cytosine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 253, doi. 10.1007/s00280-008-0862-z
- By:
- Publication type:
- Article
Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 263, doi. 10.1007/s00280-008-0865-9
- By:
- Publication type:
- Article
Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 271, doi. 10.1007/s00280-008-0866-8
- By:
- Publication type:
- Article
Protein nitration, PARP activation and NAD+ depletion may play a critical role in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis in the rat.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 279, doi. 10.1007/s00280-008-0868-6
- By:
- Publication type:
- Article
Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 287, doi. 10.1007/s00280-008-0869-5
- By:
- Publication type:
- Article
Biweekly docetaxel in recurrent ovarian cancer: a phase I dose finding study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 297, doi. 10.1007/s00280-008-0870-z
- By:
- Publication type:
- Article
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 301, doi. 10.1007/s00280-008-0871-y
- By:
- Publication type:
- Article
Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 307, doi. 10.1007/s00280-008-0872-x
- By:
- Publication type:
- Article
Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 317, doi. 10.1007/s00280-008-0873-9
- By:
- Publication type:
- Article
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 327, doi. 10.1007/s00280-008-0874-8
- By:
- Publication type:
- Article
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 335, doi. 10.1007/s00280-008-0875-7
- By:
- Publication type:
- Article
Tau expression and efficacy of paclitaxel treatment in metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 341, doi. 10.1007/s00280-008-0877-5
- By:
- Publication type:
- Article
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 347, doi. 10.1007/s00280-008-0878-4
- By:
- Publication type:
- Article
TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 355, doi. 10.1007/s00280-008-0879-3
- By:
- Publication type:
- Article
Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 361, doi. 10.1007/s00280-008-0882-8
- By:
- Publication type:
- Article
A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 371, doi. 10.1007/s00280-008-0883-7
- By:
- Publication type:
- Article
A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 379, doi. 10.1007/s00280-008-0884-6
- By:
- Publication type:
- Article
Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 385, doi. 10.1007/s00280-008-0885-5
- By:
- Publication type:
- Article
Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 391, doi. 10.1007/s00280-008-0886-4
- By:
- Publication type:
- Article
Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 401, doi. 10.1007/s00280-008-0887-3
- By:
- Publication type:
- Article
Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.
- Published in:
- 2009
- By:
- Publication type:
- Report
In vitro and in vivo study of an albumin-binding prodrug of doxorubicin that is cleaved by cathepsin B.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 413, doi. 10.1007/s00280-009-0942-8
- By:
- Publication type:
- Article
The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 419, doi. 10.1007/s00280-009-0960-6
- By:
- Publication type:
- Article
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI()), in patients with advanced solid tumours.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI<sup>™</sup>), in patients with advanced solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 425, doi. 10.1007/s00280-009-0968-y
- By:
- Publication type:
- Article
Anthocyanins-based drugs for colon cancer treatment: the nutritionist's point of view.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Anthocyanins-based drugs for colon cancer treatment: the nutritionist’s point of view.
- Published in:
- 2009
- By:
- Publication type:
- Letter